The first pathway requires a BMI greater than 27 combined with either prediabetes or established cardiovascular disease
This means it activates both the GLP-1 receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor, a hormone pathway that helps the body release insulin after eating, which may lead to greater effects on blood sugar and weight loss compared to single GLP-1 agonists
Here's the truth: snacking on GLP-1 medications like Ozempic, Wegovy, Mounjaro, or Zepbound is optionalbut strategic
Noom Med with Smart Rx , in partnership with Waltz Health, drives significant ROI for employers who wish to cover GLP-1s as a supplemental benefit such that the payer can choose the level of financial assistance they will provide Noom Weight with GLP-1 Rx delivers a proven obesity program and employee-pay access to affordable GLP-1s for employers who choose not to cover GLP-1s today New York, NY October 21, 2024 Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, is tackling the problem of GLP-1 availability, accessibility and inflated costs head-on by launching two distinct enterprise solutions that reduce obesity management costs while enabling access to life-changing medications: Noom Med with Smart Rx in partnership with Waltz Health and Noom Weight with GLP-1 Rx
My biggest regret was trying to manage everything myself
Patients describe it as: "I can finally hear myself think" or "Food used to control me
